Affordable Access

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

Authors
  • Dana, B W
  • Dahlberg, S
  • Nathwani, B N
  • Chase, E
  • Coltman, C
  • Miller, T P
  • Fisher, R I
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Apr 01, 1993
Volume
11
Issue
4
Pages
644–651
Identifiers
PMID: 8478660
Source
Medline
License
Unknown

Abstract

Doxorubicin-containing treatment did not prolong the overall median survival of low-grade lymphoma patients compared with results with less-aggressive programs.

Report this publication

Statistics

Seen <100 times